Dissecting the Relation Between a Nuclear Receptor and GATA: Binding Affinity Studies of Thyroid Hormone Receptor and GATA2 on TSHβ Promoter
Overview
Affiliations
Background: Much is known about how genes regulated by nuclear receptors (NRs) are switched on in the presence of a ligand. However, the molecular mechanism for gene down-regulation by liganded NRs remains a conundrum. The interaction between two zinc-finger transcription factors, Nuclear Receptor and GATA, was described almost a decade ago as a strategy adopted by the cell to up- or down-regulate gene expression. More recently, cell-based assays have shown that the Zn-finger region of GATA2 (GATA2-Zf) has an important role in down-regulation of the thyrotropin gene (TSHβ) by liganded thyroid hormone receptor (TR).
Methodology/principal Findings: In an effort to better understand the mechanism that drives TSHβ down-regulation by a liganded TR and GATA2, we have carried out equilibrium binding assays using fluorescence anisotropy to study the interaction of recombinant TR and GATA2-Zf with regulatory elements present in the TSHβ promoter. Surprisingly, we observed that ligand (T3) weakens TR binding to a negative regulatory element (NRE) present in the TSHβ promoter. We also show that TR may interact with GATA2-Zf in the absence of ligand, but T3 is crucial for increasing the affinity of this complex for different GATA response elements (GATA-REs). Importantly, these results indicate that TR complex formation enhances DNA binding of the TR-GATA2 in a ligand-dependent manner.
Conclusions: Our findings extend previous results obtained in vivo, further improving our understanding of how liganded nuclear receptors down-regulate gene transcription, with the cooperative binding of transcription factors to DNA forming the core of this process.
Ke S, Liu Y, Karthikraj R, Kannan K, Jiang J, Abe K JCI Insight. 2021; 6(16).
PMID: 34237030 PMC: 8410017. DOI: 10.1172/jci.insight.149425.
Protein Disulfide Isomerase Modulates the Activation of Thyroid Hormone Receptors.
Campos J, Doratioto T, Videira N, Ribeiro Filho H, Batista F, Fattori J Front Endocrinol (Lausanne). 2019; 9:784.
PMID: 30671024 PMC: 6331412. DOI: 10.3389/fendo.2018.00784.
RXR agonist modulates TR: corepressor dissociation upon 9-cis retinoic acid treatment.
Fattori J, Campos J, Doratioto T, Assis L, Vitorino M, Polikarpov I Mol Endocrinol. 2014; 29(2):258-73.
PMID: 25541638 PMC: 5414759. DOI: 10.1210/me.2014-1251.
Genome-wide binding patterns of thyroid hormone receptor beta.
Ayers S, Switnicki M, Angajala A, Lammel J, Arumanayagam A, Webb P PLoS One. 2014; 9(2):e81186.
PMID: 24558356 PMC: 3928038. DOI: 10.1371/journal.pone.0081186.
Negative regulation by nuclear receptors: a plethora of mechanisms.
Santos G, Fairall L, Schwabe J Trends Endocrinol Metab. 2011; 22(3):87-93.
PMID: 21196123 PMC: 3053446. DOI: 10.1016/j.tem.2010.11.004.